Defiance Daily Target 2X Long NVO ETF (NVOX)

Assets	$33.56M
Expense Ratio	1.31%
PE Ratio	n/a
Forward PE	n/a
Shares Out	3.12M
Dividend	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a

Volume	210,745
Open	10.64
Previous Close	10.52
Day's Range	10.60 - 11.08
52-Week Low	8.87
52-Week High	33.81
Beta	n/a
Holdings	12
Inception Date	Dec 2, 2024

About NVOX

Fund Home Page

The Defiance Daily Target 2X Long NVO ETF (NVOX) is an exchange-traded fund that mostly invests in health care stocks. The fund seeks to deliver 2x leveraged exposure to the daily share price movement of NOVO Nordisk A/S - ADR (NVO), less fees and expenses, through derivatives like swap agreements. NVOX was launched on Dec 2, 2024 and is issued by Defiance.

• Asset Class: Equity
• Category: Trading--Leveraged Equity
• Stock Exchange: NYSE Arca
• Ticker Symbol: NVOX
• ETF Provider: Defiance

Top 10 Holdings

289.24% of assets

Name	Symbol	Weight
United States Treasury Bills 0%	B.0 11.19.26	72.00%
NOVO-NORDISK SWAP MS	n/a	42.97%
NOVO-NORDISK A/S-SPONS ADR NOMURA	n/a	31.03%
NOVO-NORDISK SWAP CLEARSTREET	n/a	29.34%
NOVO-NORDISK SWAP NBC-L	n/a	28.51%
NOVO-NORDISK SWAP MAREX	n/a	28.47%
NOVO-NORDISK INC SWAP CANTOR	n/a	25.84%
OTHER ASSETS AND LIABILITIES	n/a	17.88%
NOVO-NORDISK SWAP BMO-L	n/a	11.96%
First American Government Obligs X	FGXXX	1.22%

Performance

NVOX had a total return of -50.71% in the past year, including dividends. Since the fund's inception, the average annual return has been -75.24%.

Data Sources: S&P Global Market Intelligence, CBOE, and more

Historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP. Several fund data points are also provided by Finnhub.

Last checked:

Nov 14, 2026

Data Sources Report a data error